| Contributing to the Acceleration of Clinical Trial Innovation through Efficiency and Quality Enhancement of Clinical Services
JNPMEDI (CEO Kwunho Jeong) announced on the 24th that they have recently appointed SeEun Kim as the Executive Director for the GBP Division to enhance the efficiency and quality of their clinical services.
SeEun Kim graduated from the Nursing Department of Ewha Womans University and obtained a Master's degree in Health Policy from the Graduate School of Public Health at Seoul National University. She began her career at the Clinical Trial Center of Samsung Medical Center. Subsequently, she gained extensive experience in various fields such as clinical trial operations, data management, and quality control at LSK Global PS, a Clinical Research Organization (CRO). As the Director of Business Development, she proposed optimal solutions to clinical trial sponsors through interactions with various pharmaceutical, biotech companies, and CROs both domestically and internationally.
With the addition of Executive Director Kim, JNPMEDI plans to integrate Maven CDMS, Maven Builder, and the Maven Clinical Cloud across their clinical services to further refine data and operational management processes and enhance quality. This move aims to accelerate the digital transformation (DX) of their clinical services.
JNPMEDI CEO Kwunho Jeong stated, "Executive Director Kim's diverse experience and insights in the industry will play a crucial role in planning and proposing solutions that meets our clients' various needs. Her appointment is also expected to significantly contribute to setting the future direction of the company and promoting Korea's clinical trial systems and technologies abroad."
| Contributing to the Acceleration of Clinical Trial Innovation through Efficiency and Quality Enhancement of Clinical Services
JNPMEDI (CEO Kwunho Jeong) announced on the 24th that they have recently appointed SeEun Kim as the Executive Director for the GBP Division to enhance the efficiency and quality of their clinical services.
SeEun Kim graduated from the Nursing Department of Ewha Womans University and obtained a Master's degree in Health Policy from the Graduate School of Public Health at Seoul National University. She began her career at the Clinical Trial Center of Samsung Medical Center. Subsequently, she gained extensive experience in various fields such as clinical trial operations, data management, and quality control at LSK Global PS, a Clinical Research Organization (CRO). As the Director of Business Development, she proposed optimal solutions to clinical trial sponsors through interactions with various pharmaceutical, biotech companies, and CROs both domestically and internationally.
With the addition of Executive Director Kim, JNPMEDI plans to integrate Maven CDMS, Maven Builder, and the Maven Clinical Cloud across their clinical services to further refine data and operational management processes and enhance quality. This move aims to accelerate the digital transformation (DX) of their clinical services.
JNPMEDI CEO Kwunho Jeong stated, "Executive Director Kim's diverse experience and insights in the industry will play a crucial role in planning and proposing solutions that meets our clients' various needs. Her appointment is also expected to significantly contribute to setting the future direction of the company and promoting Korea's clinical trial systems and technologies abroad."